Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples